Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4H4U0
Term | Name | Level | Count |
---|---|---|---|
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006778 | porphyrin-containing compound metabolic process | 5 | 7 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 6 | 7 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 7 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0033013 | tetrapyrrole metabolic process | 4 | 7 |
GO:0033014 | tetrapyrrole biosynthetic process | 5 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0046501 | protoporphyrinogen IX metabolic process | 6 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
GO:0006783 | heme biosynthetic process | 4 | 1 |
GO:0042168 | heme metabolic process | 3 | 1 |
GO:0042440 | pigment metabolic process | 2 | 1 |
GO:0046148 | pigment biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 7 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004729 | oxygen-dependent protoporphyrinogen oxidase activity | 5 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0010181 | FMN binding | 4 | 7 |
GO:0016491 | oxidoreductase activity | 2 | 7 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 7 |
GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 4 | 7 |
GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor | 4 | 7 |
GO:0032553 | ribonucleotide binding | 3 | 7 |
GO:0036094 | small molecule binding | 2 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043168 | anion binding | 3 | 7 |
GO:0070818 | protoporphyrinogen oxidase activity | 4 | 7 |
GO:0070819 | menaquinone-dependent protoporphyrinogen oxidase activity | 5 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:0097367 | carbohydrate derivative binding | 2 | 7 |
GO:1901265 | nucleoside phosphate binding | 3 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 13 | 17 | PF00656 | 0.426 |
CLV_C14_Caspase3-7 | 42 | 46 | PF00656 | 0.477 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.226 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.242 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.226 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.567 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.243 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.169 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.247 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.219 |
DEG_APCC_DBOX_1 | 206 | 214 | PF00400 | 0.236 |
DOC_CYCLIN_RxL_1 | 53 | 62 | PF00134 | 0.477 |
DOC_MAPK_gen_1 | 205 | 212 | PF00069 | 0.251 |
DOC_MAPK_RevD_3 | 180 | 195 | PF00069 | 0.290 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.422 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.436 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.456 |
DOC_WW_Pin1_4 | 182 | 187 | PF00397 | 0.347 |
LIG_14-3-3_CanoR_1 | 171 | 181 | PF00244 | 0.258 |
LIG_14-3-3_CanoR_1 | 67 | 75 | PF00244 | 0.369 |
LIG_14-3-3_CanoR_1 | 98 | 106 | PF00244 | 0.386 |
LIG_APCC_ABBAyCdc20_2 | 160 | 166 | PF00400 | 0.280 |
LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.477 |
LIG_BRCT_BRCA1_1 | 87 | 91 | PF00533 | 0.336 |
LIG_BRCT_BRCA1_2 | 68 | 74 | PF00533 | 0.419 |
LIG_CSL_BTD_1 | 119 | 122 | PF09270 | 0.206 |
LIG_deltaCOP1_diTrp_1 | 166 | 173 | PF00928 | 0.265 |
LIG_FHA_1 | 157 | 163 | PF00498 | 0.301 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.434 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.386 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.155 |
LIG_FHA_2 | 150 | 156 | PF00498 | 0.226 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.426 |
LIG_GBD_Chelix_1 | 192 | 200 | PF00786 | 0.543 |
LIG_LIR_Gen_1 | 165 | 174 | PF02991 | 0.253 |
LIG_LIR_Gen_1 | 175 | 184 | PF02991 | 0.306 |
LIG_LIR_Gen_1 | 52 | 61 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 52 | 57 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.356 |
LIG_MLH1_MIPbox_1 | 87 | 91 | PF16413 | 0.403 |
LIG_NRP_CendR_1 | 229 | 231 | PF00754 | 0.333 |
LIG_PCNA_yPIPBox_3 | 98 | 110 | PF02747 | 0.386 |
LIG_Pex14_1 | 133 | 137 | PF04695 | 0.230 |
LIG_Pex14_2 | 173 | 177 | PF04695 | 0.249 |
LIG_REV1ctd_RIR_1 | 137 | 146 | PF16727 | 0.254 |
LIG_SH2_CRK | 65 | 69 | PF00017 | 0.369 |
LIG_SH2_STAP1 | 110 | 114 | PF00017 | 0.426 |
LIG_SH2_STAP1 | 164 | 168 | PF00017 | 0.272 |
LIG_SH2_STAP1 | 54 | 58 | PF00017 | 0.426 |
LIG_SH2_STAT3 | 75 | 78 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.418 |
LIG_SH3_3 | 116 | 122 | PF00018 | 0.413 |
LIG_SUMO_SIM_par_1 | 180 | 185 | PF11976 | 0.239 |
LIG_SUMO_SIM_par_1 | 39 | 45 | PF11976 | 0.477 |
LIG_TYR_ITIM | 63 | 68 | PF00017 | 0.415 |
LIG_UBA3_1 | 22 | 28 | PF00899 | 0.377 |
MOD_CDK_SPxxK_3 | 182 | 189 | PF00069 | 0.276 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.322 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.350 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.226 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.369 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.635 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.314 |
MOD_GlcNHglycan | 82 | 86 | PF01048 | 0.240 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.181 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.364 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.259 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.437 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.226 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.345 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.396 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.494 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.424 |
MOD_N-GLC_1 | 203 | 208 | PF02516 | 0.539 |
MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.247 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.454 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.248 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.460 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.223 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.430 |
MOD_PKA_1 | 194 | 200 | PF00069 | 0.347 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.369 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.436 |
MOD_Plk_1 | 203 | 209 | PF00069 | 0.338 |
MOD_Plk_1 | 81 | 87 | PF00069 | 0.427 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.426 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.456 |
MOD_ProDKin_1 | 182 | 188 | PF00069 | 0.355 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.248 |
TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.456 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.418 |
TRG_ER_diArg_1 | 205 | 208 | PF00400 | 0.339 |
TRG_ER_diArg_1 | 228 | 231 | PF00400 | 0.536 |
TRG_Pf-PMV_PEXEL_1 | 142 | 146 | PF00026 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P9Q7 | Leptomonas seymouri | 60% | 100% |
A0A3S5H5V3 | Leishmania donovani | 78% | 100% |
A4HT19 | Leishmania infantum | 77% | 100% |
E9AL08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
P0ACB4 | Escherichia coli (strain K12) | 47% | 100% |
P0ACB5 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 47% | 100% |
P0ACB6 | Escherichia coli O157:H7 | 47% | 100% |
Q4QIU7 | Leishmania major | 78% | 100% |
Q9L6L1 | Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) | 47% | 100% |